45 LIBERTY BLVD., MALVERN, PA
Other Events
Stock Increase and Written Consent Amendments Approved by Stockholders
Director Elections and Say-on-Pay Approval at Galera Therapeutics
Annual Report to Security Holders
Announce Merger Agreement and $350 Million Concurrent Private Placement, Investor Presentation
Q1
FY 2025
Q3
Q2
FY 2024
Notice of Late Filing for Quarterly Report
Prospectus Filed Pursuant to Rule 425
Definitive Additional Proxy Soliciting Materials
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Schedule 13D - Ownership Report
Statement of Changes in Beneficial Ownership
Amended Schedule 13D - Ownership Report
Initial Statement of Beneficial Ownership
Correspondence
Submission Upload
Deregistration Letter